{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:00:57Z","timestamp":1781067657789,"version":"3.54.1"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The FAST-Forward trial demonstrated the non-inferiority of 26 Gy in five fractions compared to 40 Gy in 15 fractions over five years. This study aimed to report observed breast toxicities and examine the impact of dosimetric parameters in ultra-hypofractionated radiotherapy (RT) across a diverse patient population in Saudi Arabia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This multi-institutional retrospective study evaluated 100 breast cancer patients treated with whole-breast adjuvant radiotherapy (26 Gy in 5 fractions) between June 2020 and June 2023, with adjuvant RT at two different institutions in Saudi Arabia. Breast toxicity data were retrospectively collected from medical chart review and verbal reports from patients lost to follow-up. Correlations between dosimetric factors, body mass index (BMI), and acute and late toxicity symptoms were statistically assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 85 patients were included in the analysis after excluding those with incomplete toxicity data with a median follow-up of 19 months. Breast skin dermatitis was the most common side effect (82.35%, n=70) with 5% of patients experiencing Grade III, followed by hyperpigmentation (72.9%, n=62), breast discomfort (30.3%, n=26) and breast hardness (17.6%, n=15). Breast pain rated \u22655 out of 10 on the pain scale was reported in 15% of cases. Breast pain had a significant correlation with larger breast volume and higher V107% values (p=0.013, and p=0.012 respectively). Furthermore, breast skin dermatitis was significantly correlated with breast CTV, BMI, and breast separation (p=0.0001, 0.015, and 0.001 respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Ultra-hypofractionated RT with a 26 Gy in five fractions schedule was well tolerated in our patient cohort. A larger breast volume, higher BMI, and increased V105% and V107% were associated with greater toxicity. Optimizing modifiable dosimetric factors may reduce adverse effects. Consequently, these findings offer valuable insights into treatment refinement.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1861707","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:29:20Z","timestamp":1781065760000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimizing outcomes with less than more: multi-institutional experience of fast-forward fractionation and the impact of dosimetric parameters on toxicity in breast cancer patients"],"prefix":"10.3389","volume":"16","author":[{"given":"H.","family":"Habibullah","sequence":"first","affiliation":[{"name":"Department of Oncology, King Faisal Specialist Hospital and Research Centre","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Alotaibi","sequence":"additional","affiliation":[{"name":"Department of Oncology, King Faisal Specialist Hospital and Research Centre","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Almarzouki","sequence":"additional","affiliation":[{"name":"Department of Radiology, Faculty of Medicine, King Abdulaziz University","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Mulla","sequence":"additional","affiliation":[{"name":"Department of Oncology, King Faisal Specialist Hospital and Research Centre","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Elbaiomy","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, Oncology Center, Mansoura University","place":["Madinah, Egypt"]},{"name":"Department of Oncology, King Salman Bin Abdulaziz Medical City","place":["Medinah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Alahmadi","sequence":"additional","affiliation":[{"name":"Department of Radiology, Faculty of Medicine, King Abdulaziz University","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Oncology, King Faisal Specialist Hospital and Research Centre","place":["Jeddah, Saudi Arabia"]},{"name":"Department of Clinical Oncology, Sohag University Hospital","place":["Sohag, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Bahadur","sequence":"additional","affiliation":[{"name":"Department of Radiology, Faculty of Medicine, King Abdulaziz University","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Ujaimi","sequence":"additional","affiliation":[{"name":"Department of Radiology, Faculty of Medicine, King Abdulaziz University","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Senan","sequence":"additional","affiliation":[{"name":"Department of Oncology, King Faisal Specialist Hospital and Research Centre","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Attar","sequence":"additional","affiliation":[{"name":"Department of Radiology, Faculty of Medicine, King Abdulaziz University","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bamakhramah","sequence":"additional","affiliation":[{"name":"Department of Oncology, King Faisal Specialist Hospital and Research Centre","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Altoukhi","sequence":"additional","affiliation":[{"name":"Department of Radiology, Faculty of Medicine, King Abdulaziz University","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Muamenah","sequence":"additional","affiliation":[{"name":"Department of Oncology, King Faisal Specialist Hospital and Research Centre","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Iskanderani","sequence":"additional","affiliation":[{"name":"Department of Radiology, Faculty of Medicine, King Abdulaziz University","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Garout","sequence":"additional","affiliation":[{"name":"Department of Oncology, King Faisal Specialist Hospital and Research Centre","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Alturkistani","sequence":"additional","affiliation":[{"name":"Department of Oncology, King Faisal Specialist Hospital and Research Centre","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Hijazi","sequence":"additional","affiliation":[{"name":"Department of Radiology, Faculty of Medicine, King Abdulaziz University","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Jastaniah","sequence":"additional","affiliation":[{"name":"Department of Radiology, Faculty of Medicine, King Abdulaziz University","place":["Jeddah, Saudi Arabia"]},{"name":"Department of Internal Medicine, Faculty of Medicine, King Abdulaziz University","place":["Rabigh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jksus.2021.101578","article-title":"Incidence trends of breast cancer in Saudi Arabia: a joinpoint regression analysis [2004\u20132016","volume":"33","author":"Albeshan","year":"2021","journal-title":"J King Saud Univ Sci"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1186\/s12889-019-7942-3","article-title":"Determinants of breast cancer in saudi women from makkah region: a case-control study (breast cancer risk factors among saudi women)","volume":"19","author":"Alsolami","year":"2019","journal-title":"BMC Public Health"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.6664","article-title":"Incidence rates of breast cancer by age and tumor characteristics among saudi women: recent trends","volume":"12","author":"Asiri","year":"2020","journal-title":"Cureus"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2018.05.045","article-title":"Breast cancer in the gcc countries: a focus on brca1\/2 and non-brca1\/2 genes","volume":"668","author":"Rahman","year":"2018","journal-title":"Gene"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials","volume":"378","author":"Darby","year":"2011","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.15526","article-title":"Locally advanced breast cancer: treatment patterns and predictors of survival in a saudi tertiary center","volume":"13","author":"Trabulsi","year":"2021","journal-title":"Cureus"},{"key":"B7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.radonc.2004.04.004","article-title":"Adjuvant radiotherapy for breast cancer: effects of longer follow-up","volume":"72","author":"Van de Steene","year":"2004","journal-title":"Radiother Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1159\/000439007","article-title":"Hypofractionated radiotherapy as adjuvant treatment in early breast cancer. a review and meta-analysis of randomized controlled trials","volume":"10","author":"Budach","year":"2015","journal-title":"Breast Care (Basel)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70077-9","article-title":"The uk standardization of breast radiotherapy (start) trial a of radiotherapy hypofractionation for treatment of early breast cancer: a randomized trial","volume":"9","author":"Bentzen","year":"2008","journal-title":"Lancet Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60348-7","article-title":"The uk standardization of breast radiotherapy (start) trial b of radiotherapy hypofractionation for treatment of early breast cancer: a randomized trial","volume":"371","author":"Bentzen","year":"2008","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (fast-forward): 5-year efficacy and late normal tissue effects results from a multicenter, non-inferiority, randomized, phase 3 trial","volume":"395","author":"Murray Brunt","year":"2020","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/wwbf1044","article-title":"One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the fast-forward phase iii rct","volume":"27","author":"Brunt","year":"2023","journal-title":"Health Technol Assess"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(18)30813-1","article-title":"Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomized, non-inferiority, open-label, phase 3 trial","volume":"20","author":"Wang","year":"2019","journal-title":"Lancet Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-020-01744-3","article-title":"Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: considerations regarding fast and fast-forward","volume":"197","author":"Krug","year":"2021","journal-title":"Strahlenther Onkol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2024.101476","article-title":"Master breast radiation planning: simple guide for radiation oncology residents","volume":"9","author":"Arbab","year":"2024","journal-title":"Adv Radiat Oncol"},{"key":"B16","article-title":"Outcome Measures","year":"2019"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.738851","article-title":"Risk factors related to acute radiation dermatitis in breast cancer patients after radiotherapy: a systematic review and meta-analysis","volume":"11","author":"Xie","year":"2021","journal-title":"Front Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2478\/raon-2018-0026","article-title":"Breast size impact on adjuvant radiotherapy adverse effects and dose parameters in treatment planning","volume":"52","author":"Ratosa","year":"2018","journal-title":"Radiol Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/s0167-8140(97)00054-6","article-title":"Patterns of dose variability in radiation prescription of breast cancer","volume":"44","author":"Das","year":"1997","journal-title":"Radiother Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(13)70386-3","article-title":"The uk standardization of breast radiotherapy (start) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomized controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2018.01.012","article-title":"Radiation therapy for the whole breast: executive summary of an american society for radiation oncology (astro) evidence-based guideline","volume":"8","author":"Smith","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2018.08.024","article-title":"Hypofractionated whole-breast irradiation in large-breasted women-is there a dosimetric predictor for acute skin toxicities","volume":"103","author":"Patel","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2026.01.005","article-title":"The critical role of dose homogeneity in modern breast hypofractionation","volume":"116","author":"Sourial","year":"2026","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1200\/go-24-00488","article-title":"Impact of hypofractionated radiation protocols on reducing travel burden and improving patient satisfaction: when less is more","volume":"11","author":"Mulla","year":"2025","journal-title":"JCO Glob Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-017-1115-z","article-title":"Better compliance with hypofractionation vs. conventional fractionation in adjuvant breast cancer radiotherapy: results of a single, institutional, retrospective study","volume":"193","author":"Rudat","year":"2017","journal-title":"Strahlenther Onkol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1136357","article-title":"Expanding radiotherapy access in sub-saharan africa: an analysis of travel burdens and patient-related benefits of hypofractionation","volume":"13","author":"Patel","year":"2023","journal-title":"Front Oncol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.clbc.2024.03.007","article-title":"Hypofractionation for regional nodal irradiation in breast cancer: best of both the worlds","volume":"24","author":"Yadav","year":"2024","journal-title":"Clin Breast Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/jmrs.530","article-title":"New fractionations in breast cancer: a dosimetric study of 3d-crt versus vmat","volume":"69","author":"Piras","year":"2021","journal-title":"J Med Radiat Sci"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1861707\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:29:21Z","timestamp":1781065761000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1861707\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":28,"alternative-id":["10.3389\/fonc.2026.1861707"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1861707","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"article-number":"1861707"}}